← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 15, 2019Last known activity
Sep 3, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04115072Lead sponsorPhase 2/Phase 3Sep 3, 2019
- NCT05013593Reponsible party - principal investigatorN/AJul 15, 2019
- NCT05013593Overall official - principal investigatorN/AJul 15, 2019
- NCT05013593Lead sponsorN/AJul 15, 2019
Details
- Last known activity
- Sep 3, 2019